Showing 1 to 12 of 12 results
Russia's Mifepristone Restrictions Cause Nationwide Contraceptive Shortage
Russia's September 2024 reclassification of mifepristone as a controlled substance has led to a nationwide shortage of emergency contraceptives and medical abortion drugs, impacting women's reproductive healthcare access amid a demographic crisis and record-low birth rates.
Russia's Mifepristone Restrictions Cause Nationwide Contraceptive Shortage
Russia's September 2024 reclassification of mifepristone as a controlled substance has led to a nationwide shortage of emergency contraceptives and medical abortion drugs, impacting women's reproductive healthcare access amid a demographic crisis and record-low birth rates.
Progress
32% Bias Score
Trump FDA Dismisses Lawsuit Challenging Abortion Drug Mifepristone
The Trump administration's FDA moved to dismiss a lawsuit from conservative states aiming to limit access to the abortion drug mifepristone, echoing the Biden administration's position; medication abortions now comprise 63% of all abortions in the U.S.
Trump FDA Dismisses Lawsuit Challenging Abortion Drug Mifepristone
The Trump administration's FDA moved to dismiss a lawsuit from conservative states aiming to limit access to the abortion drug mifepristone, echoing the Biden administration's position; medication abortions now comprise 63% of all abortions in the U.S.
Progress
40% Bias Score
Trump Administration Defends Mifepristone Access Amidst Legal Challenge
The Trump administration is defending FDA regulations easing access to the abortion drug mifepristone against a lawsuit by three Republican-led states, arguing the states lack standing to sue in Texas federal court, while the states claim their Medicaid programs might have to pay for complications.
Trump Administration Defends Mifepristone Access Amidst Legal Challenge
The Trump administration is defending FDA regulations easing access to the abortion drug mifepristone against a lawsuit by three Republican-led states, arguing the states lack standing to sue in Texas federal court, while the states claim their Medicaid programs might have to pay for complications.
Progress
32% Bias Score
ADF Intensifies Efforts to Restrict Abortion Access in the US
The Alliance Defending Freedom (ADF), a conservative legal group, is employing various legal strategies to restrict abortion access in the US, including lawsuits targeting medication abortion and efforts to defund Planned Parenthood, following the overturning of Roe v. Wade.
ADF Intensifies Efforts to Restrict Abortion Access in the US
The Alliance Defending Freedom (ADF), a conservative legal group, is employing various legal strategies to restrict abortion access in the US, including lawsuits targeting medication abortion and efforts to defund Planned Parenthood, following the overturning of Roe v. Wade.
Progress
64% Bias Score
Ulipristal Acetate Shows Promise as Abortion Medication
A study showed that a higher dose of ulipristal acetate, the active ingredient in the emergency contraceptive ellaOne, was 97% effective in inducing abortion in 133 women up to nine weeks pregnant when combined with misoprostol, potentially offering an alternative to mifepristone.
Ulipristal Acetate Shows Promise as Abortion Medication
A study showed that a higher dose of ulipristal acetate, the active ingredient in the emergency contraceptive ellaOne, was 97% effective in inducing abortion in 133 women up to nine weeks pregnant when combined with misoprostol, potentially offering an alternative to mifepristone.
Progress
36% Bias Score
Ulipristal Acetate Shows High Effectiveness in Medication Abortion
A new study demonstrates the 97% effectiveness of ulipristal acetate, an emergency contraceptive, in medication abortions up to nine weeks, offering a potential alternative to mifepristone and raising concerns about potential restrictions on emergency contraception.
Ulipristal Acetate Shows High Effectiveness in Medication Abortion
A new study demonstrates the 97% effectiveness of ulipristal acetate, an emergency contraceptive, in medication abortions up to nine weeks, offering a potential alternative to mifepristone and raising concerns about potential restrictions on emergency contraception.
Progress
48% Bias Score
US Abortion Numbers Rise Despite State Bans
In 2024, a record 1.14 million abortions were performed in the US, despite bans in numerous states; this increase is largely due to telehealth abortions facilitated by "shield laws", while reported in-person abortions in states with total bans averaged only 30 per month.
US Abortion Numbers Rise Despite State Bans
In 2024, a record 1.14 million abortions were performed in the US, despite bans in numerous states; this increase is largely due to telehealth abortions facilitated by "shield laws", while reported in-person abortions in states with total bans averaged only 30 per month.
Progress
48% Bias Score
Trump Administration Defends Mifepristone Access in Legal Challenge
The Trump administration is defending FDA rules easing access to the abortion drug mifepristone against a lawsuit by three Republican states, arguing they lack standing and Texas is an improper venue; this maintains current access levels, affecting abortion availability nationwide.
Trump Administration Defends Mifepristone Access in Legal Challenge
The Trump administration is defending FDA rules easing access to the abortion drug mifepristone against a lawsuit by three Republican states, arguing they lack standing and Texas is an improper venue; this maintains current access levels, affecting abortion availability nationwide.
Progress
44% Bias Score
Trump Administration Moves to Dismiss Lawsuit Challenging Mifepristone Access
The Trump administration filed to dismiss a lawsuit from Idaho, Kansas, and Missouri seeking to restrict telehealth access to the abortion medication mifepristone, arguing the states lack legal standing and that their challenge to 2016 FDA actions is beyond the statute of limitations.
Trump Administration Moves to Dismiss Lawsuit Challenging Mifepristone Access
The Trump administration filed to dismiss a lawsuit from Idaho, Kansas, and Missouri seeking to restrict telehealth access to the abortion medication mifepristone, arguing the states lack legal standing and that their challenge to 2016 FDA actions is beyond the statute of limitations.
Progress
44% Bias Score
Kennedy's Abortion Pledge: Impact on Mifepristone Regulation
Robert F. Kennedy Jr. pledged at a Senate hearing to implement President Trump's abortion policies if confirmed as HHS Secretary, prompting praise from some conservative groups and alarm from Democrats who cited his past pro-choice statements. This decision significantly impacts abortion access nati...
Kennedy's Abortion Pledge: Impact on Mifepristone Regulation
Robert F. Kennedy Jr. pledged at a Senate hearing to implement President Trump's abortion policies if confirmed as HHS Secretary, prompting praise from some conservative groups and alarm from Democrats who cited his past pro-choice statements. This decision significantly impacts abortion access nati...
Progress
56% Bias Score
Ulipristal Acetate Shows Promise as Abortion Alternative
A new study published in NEJM Evidence reveals that a 60mg dose of ulipristal acetate, when combined with misoprostol, effectively induced abortion in 97% of women up to nine weeks pregnant, offering a potential alternative to mifepristone amidst legal challenges.
Ulipristal Acetate Shows Promise as Abortion Alternative
A new study published in NEJM Evidence reveals that a 60mg dose of ulipristal acetate, when combined with misoprostol, effectively induced abortion in 97% of women up to nine weeks pregnant, offering a potential alternative to mifepristone amidst legal challenges.
Progress
52% Bias Score
New Jersey to Stockpile Abortion Medication, Defying Potential Federal Restrictions
New Jersey Governor Phil Murphy announced Tuesday that his state will stockpile mifepristone, a medication used in abortions, to ensure access to reproductive healthcare, defying potential federal restrictions under the incoming Trump administration, joining similar efforts in Massachusetts and Cali...
New Jersey to Stockpile Abortion Medication, Defying Potential Federal Restrictions
New Jersey Governor Phil Murphy announced Tuesday that his state will stockpile mifepristone, a medication used in abortions, to ensure access to reproductive healthcare, defying potential federal restrictions under the incoming Trump administration, joining similar efforts in Massachusetts and Cali...
Progress
40% Bias Score
Showing 1 to 12 of 12 results